Literature DB >> 8034632

Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis.

J M Lo-Guidice1, J M Wieruszeski, J Lemoine, A Verbert, P Roussel, G Lamblin.   

Abstract

Mucin glycopeptides were prepared from the sputum of a patient suffering from cystic fibrosis. The carbohydrate chains were released by alkaline borohydride treatment. Sialylated and sulfated oligosaccharide-alditols were purified by ion-exchange chromatography, gel filtration, and high performance anion-exchange chromatography. The structures of the oligosaccharide-alditols were determined by high resolution 1H NMR spectroscopy in combination with fast atom bombardment-mass spectrometry. Twenty-four oligosaccharides were characterized and illustrate the diversity of the carbohydrate chains of cystic fibrosis respiratory mucins. Among these 24 oligosaccharide-alditols, 15 are novel structures. Sialylation may occur on the C-6 of the N-acetylgalactosamine involved in the carbohydrate-peptide linkage or on a terminal galactose residue, either on C-3 or on C-6. Sulfation may occur either on the C-3 of a terminal galactose residue or on the C-6 of a N-acetylglucosamine residue. The most complex structures contain sulfated derivatives of the H,X, or Y determinants or a sialylated and sulfated derivative of the X determinant (Structure A).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034632

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells.

Authors:  J Mendicino; S Sangadala
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  Therapeutic targeting of endothelial ligands for L-selectin (PNAd) in a sheep model of asthma.

Authors:  Steven D Rosen; Durwin Tsay; Mark S Singer; Stefan Hemmerich; William M Abraham
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

3.  Search for additional influenza virus to cell interactions.

Authors:  E M Rapoport; L V Mochalova; H-J Gabius; J Romanova; N V Bovin
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

4.  Characterization of a spleen sulphotransferase responsible for the 6-O-sulphation of the galactose residue in sialyl-N-acetyl-lactosamine sequences.

Authors:  R G Spiro; V D Bhoyroo
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

5.  Characterization of novel O-glycans isolated from tear and saliva of ocular rosacea patients.

Authors:  Sureyya Ozcan; Hyun Joo An; Ana C Vieira; Gun Wook Park; Jae Han Kim; Mark J Mannis; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2013-02-06       Impact factor: 4.466

6.  Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.

Authors:  P Delannoy; I Kim; N Emery; C De Bolos; A Verbert; P Degand; G Huet
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 7.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

Review 8.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

9.  A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.

Authors:  P J French; J H van Doorninck; R H Peters; E Verbeek; N A Ameen; C R Marino; H R de Jonge; J Bijman; B J Scholte
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

10.  Expression of DeltaF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation.

Authors:  Amrita Dosanjh; Elaine A Muchmore
Journal:  Open Respir Med J       Date:  2009-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.